entertainment -WSS

entertainment

author：knowledge 2025-09-28 23:49:00 - browse：689

A masked person wears Onward Medical’s non-invasive spinal cord stimulator, solving a Rubik's cube — health tech coverage from STAT — Courtesy Onward Medical

After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat.

So when Campbell started sweating on his stationary bike for the first time in seven years, it felt surreal. It was late 2021, and Campbell was nearing the end of a clinical trial testing out a device to help paralyzed patients regain movement.

“I felt really refreshed and excited, because you get to this point where normally I’d have to back off or monitor if I’m overheating,” Campbell, 41, said. “To break through that, it just feels clear.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： RaDonda Vaught case: a double standard for nurses, physicians

WSS

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Doctor appointment wait times are getting worse

4th of July breaks record for highest global temperature ever measured

NIH tests clinical research in primary care with $30 million program

Community addresses injustice for Long Island mothers

Lilly's Alzheimer's drug donanemab backed by FDA advisers

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Walensky prepares to leave CDC — and Congress — behind

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Activists slam private health insurers over coverage restrictions

How faith leaders like me can help address America's obesity epidemic

Wildfire smoke exposes gaps in outdoor worker protections

4th of July breaks record for highest global temperature ever measured

Walensky prepares to leave CDC — and Congress — behind

Moderna says combo Covid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Van's Gluten Free Original Waffles recalled for possible wheat allergen

knowledge

NIH tests clinical research in primary care with $30 million program

California wildfire smoke linked to 52,000 early deaths, study says

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Meta looks to target Twitter with a rival app called Threads

Pfizer's Covid pill remains 89% effective in final analysis, company says

Meta looks to target Twitter with a rival app called Threads

knowledge

explore

hotspot

hotspot